Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma

Chinese journal of cancer

Volumn 35, Issue 1, 2016, Pages 97-

  Kuczynski, Elizabeth A ^a   Kerbel, Robert S ^a  

^a Canada   (Canada)

Author keywords

Hepatocellular carcinoma; Non angiogenic; Resistance; Sorafenib; Vessel co option

Indexed keywords

ANTINEOPLASTIC AGENT; CARBANILAMIDE DERIVATIVE; NICOTINAMIDE; SORAFENIB;

ANALOGS AND DERIVATIVES; ANIMAL; CARCINOMA, HEPATOCELLULAR; DRUG RESISTANCE; HUMAN; LIVER NEOPLASMS; MOUSE; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DRUG RESISTANCE, NEOPLASM; HUMANS; LIVER NEOPLASMS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NIACINAMIDE; PHENYLUREA COMPOUNDS;

EID: 85015353538     PISSN: None     EISSN: 1944446X     Source Type: Journal    
DOI: 10.1186/s40880-016-0162-7     Document Type: Article

References (0)